TVA-Recherche.fr

TVA-Recherche à


Toutes les informations sur:

                        
Nom

Virothera LTD

Adresse
St. Johns Innovation Park
Cowley Road
Cambridge
CB4 0WS
VAT ID (Numéro de TVA)
État de Tva actif inactif National Registration Only
VAT Registration Date
31 mars 2019
Société Numéro de Registre 10884160 Show on Companies House
Accountstotal-exemption-full
last accounts made up to 30 septembre 2022
Activité (Code NAF)72110 - Recherche-développement en biotechnologie
Statut de Sociétéactive
Noms Précédents
  • Virokine Therapeutics LTD
  • KYC Check
    KYC / PEP / AML request
    This data is incorrect?
    Source: VAT information: HMRC (gov.uk/check-uk-vat-number), Company Register: Companies House (companieshouse.gov.uk)

    Quick access

    Persons with Significant Control (1)

    Source: Companies House
    Gompels, Ursula Adele Status: Active Notified: 26/07/2017 Date of Birth: 12/1957 Nature of Control
  • Ownership of shares – More than 50% but not more than 75%
  • Ownership of voting rights - More than 50% but not more than 75%
  • Right to appoint and remove directors
  • Officers (4)

    Source: Companies House
    Gompels, Ursula Adele Cambridge, England Status: Active Notified: 26/07/2017 Date of Birth: 12/1957 Occupation: Director Role: Director Country of Residence: United Kingdom Nationality: British
    Gompels, Ursula Adele, Dr Cambridge, England Status: Active Notified: 26/07/2017 Occupation: Director Role: Director Country of Residence: England Nationality: British
    Hotten, Peter Martin Cambridge, England Status: Active Notified: 23/10/2020 Date of Birth: 05/1956 Occupation: Company Director Role: Director Country of Residence: England Nationality: British
    Wright, David Cambridge, England Status: Active Notified: 01/09/2023 Occupation: Director Role: Director Country of Residence: England Nationality: British

    Companies Controlled by This Company (1)

    gb-flag GB Virokine Therapeutics LTD Status: Active Notified: 23/03/2020 Companies House Number: 12529350 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more